Ross Muken
Stock Analyst at Evercore ISI Group
(2.90)
# 1,671
Out of 5,127 analysts
47
Total ratings
65.38%
Success rate
5.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Outperform | $190 → $200 | $215.51 | -7.20% | 9 | Oct 3, 2025 | |
| HSIC Henry Schein | Maintains: In-Line | $78 → $70 | $79.00 | -11.39% | 10 | Aug 6, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $170 → $240 | $188.22 | +27.51% | 9 | Jul 25, 2025 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $145.76 | -10.81% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $48.45 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $202.49 | -66.91% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $145.83 | +71.43% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $606.50 | -63.73% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $11.24 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Oct 3, 2025
Maintains: Outperform
Price Target: $190 → $200
Current: $215.51
Upside: -7.20%
Henry Schein
Aug 6, 2025
Maintains: In-Line
Price Target: $78 → $70
Current: $79.00
Upside: -11.39%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $170 → $240
Current: $188.22
Upside: +27.51%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $145.76
Upside: -10.81%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $48.45
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $202.49
Upside: -66.91%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $145.83
Upside: +71.43%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $606.50
Upside: -63.73%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $11.24
Upside: -